Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Eva S Schernhammer, M.D.

TitleAssociate Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
Channing Division of Network Medicine, 444
181 Longwood Ave
Boston MA 02115
Phone617/525-4648
Fax617/525-2008
Other Positions
TitleAssociate Professor in the Department of Epidemiology
InstitutionHarvard School of Public Health
DepartmentEpidemiology


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Devore EE, Grodstein F, Schernhammer ES. Shift work and cognition in the nurses' health study. Am J Epidemiol. 2013 Oct 15; 178(8):1296-300.
    View in: PubMed
  2. Stevens RG, Hansen J, Schernhammer ES, Davis S. Response to Ijaz S, et al. "Night-shift work and breast cancer - a systematic review and meta-analysis". Scand J Work Environ Health. 2013 Nov 1; 39(6):631-2.
    View in: PubMed
  3. Schernhammer ES, Feskanich D, Liang G, Han J. Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol. 2013 Nov 1; 178(9):1434-41.
    View in: PubMed
  4. Ramin C, Devore EE, Pierre-Paul J, Duffy JF, Hankinson SE, Schernhammer ES. Chronotype and Breast Cancer Risk in a Cohort of US Nurses. Chronobiol Int. 2013 Nov; 30(9):1181-6.
    View in: PubMed
  5. McMullan CJ, Schernhammer ES, Forman JP. Melatonin level and risk for type 2 diabetes--in reply. JAMA. 2013 Aug 7; 310(5):537.
    View in: PubMed
  6. McMullan CJ, Curhan GC, Schernhammer ES, Forman JP. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013 Jul 15; 178(2):231-8.
    View in: PubMed
  7. Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):872-9.
    View in: PubMed
  8. Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep. 2013; 36(5):681-8.
    View in: PubMed
  9. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013 Apr 3; 309(13):1388-96.
    View in: PubMed
  10. Schernhammer E, Qiu J, Wermuth L, Lassen CF, Friis S, Ritz B. Gout and the risk of Parkinson's disease in Denmark. Eur J Epidemiol. 2013 Apr; 28(4):359-60.
    View in: PubMed
  11. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 26(4):465-84.
    View in: PubMed
  12. Ogino S, Nishihara R, Lochhead P, Imamura Y, Kuchiba A, Morikawa T, Yamauchi M, Liao X, Qian ZR, Sun R, Sato K, Kirkner GJ, Wang M, Spiegelman D, Meyerhardt JA, Schernhammer ES, Chan AT, Giovannucci E, Fuchs CS. Prospective Study of Family History and Colorectal Cancer Risk by Tumor LINE-1 Methylation Level. J Natl Cancer Inst. 2013 Jan 16; 105(2):130-40.
    View in: PubMed
  13. Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WC, Feskanich D. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr. 2012 Dec; 96(6):1419-28.
    View in: PubMed
  14. Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 2012 Dec 1; 131(11):2547-52.
    View in: PubMed
  15. Li WQ, Qureshi AA, Schernhammer ES, Han J. Rotating Night-Shift Work and Risk of Psoriasis in US Women. J Invest Dermatol. 2013 Feb; 133(2):565-7.
    View in: PubMed
  16. Thompson CA, Waldhör T, Schernhammer ES, Hackl M, Vutuc C, Haidinger G. Smoking and lung cancer: current trends in Austria. Wien Klin Wochenschr. 2012 Aug; 124(15-16):493-9.
    View in: PubMed
  17. Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, Mucci LA. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1002-11.
    View in: PubMed
  18. Schernhammer ES, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Chen WY. A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. Cancer Causes Control. 2012 Apr; 23(4):609-16.
    View in: PubMed
  19. Bonde JP, Hansen J, Kolstad HA, Mikkelsen S, Olsen JH, Blask DE, Härmä M, Kjuus H, de Koning HJ, Olsen J, Møller M, Schernhammer ES, Stevens RG, Åkerstedt T. Work at night and breast cancer--report on evidence-based options for preventive actions. Scand J Work Environ Health. 2012 Jul; 38(4):380-90.
    View in: PubMed
  20. Lieu SJ, Curhan GC, Schernhammer ES, Forman JP. Rotating night shift work and disparate hypertension risk in African-Americans. J Hypertens. 2012 Jan; 30(1):61-6.
    View in: PubMed
  21. Pan A, Schernhammer ES, Sun Q, Hu FB. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011 Dec; 8(12):e1001141.
    View in: PubMed
  22. Liang G, Schernhammer E, Qi L, Gao X, De Vivo I, Han J. Associations between rotating night shifts, sleep duration, and telomere length in women. PLoS One. 2011; 6(8):e23462.
    View in: PubMed
  23. Poole EM, Tworoger SS, Hankinson SE, Schernhammer ES, Pollak MN, Baer HJ. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol. 2011 Sep 15; 174(6):642-51.
    View in: PubMed
  24. Bajaj A, Rosner B, Lockley SW, Schernhammer ES. Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaire. Cancer Epidemiol Biomarkers Prev. 2011 Jul; 20(7):1341-9.
    View in: PubMed
  25. Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PLoS One. 2011; 6(6):e21102.
    View in: PubMed
  26. Schernhammer ES, Vitonis AF, Rich-Edwards J, Missmer SA. Rotating nightshift work and the risk of endometriosis in premenopausal women. Am J Obstet Gynecol. 2011 Nov; 205(5):476.e1-8.
    View in: PubMed
  27. Schernhammer ES, Stone KL. Light pollution???light pollution? Chronobiol Int. 2011 May; 28(4):378-9; author reply 379-80.
    View in: PubMed
  28. Lawson CC, Whelan EA, Lividoti Hibert EN, Spiegelman D, Schernhammer ES, Rich-Edwards JW. Rotating shift work and menstrual cycle characteristics. Epidemiology. 2011 May; 22(3):305-12.
    View in: PubMed
  29. Manthripragada AD, Schernhammer ES, Qiu J, Friis S, Wermuth L, Olsen JH, Ritz B. Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease. Neuroepidemiology. 2011; 36(3):155-61.
    View in: PubMed
  30. Poole EM, Schernhammer ES, Tworoger SS. Rotating night shift work and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):934-8.
    View in: PubMed
  31. Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care. 2011 May; 34(5):1102-8.
    View in: PubMed
  32. Schernhammer ES, Razavi P, Li TY, Qureshi AA, Han J. Rotating night shifts and risk of skin cancer in the nurses' health study. J Natl Cancer Inst. 2011 Apr 6; 103(7):602-6.
    View in: PubMed
  33. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, Castaño-Vinyals G, Davis S, Frings-Dresen MH, Fritschi L, Kogevinas M, Kogi K, Lie JA, Lowden A, Peplonska B, Pesch B, Pukkala E, Schernhammer E, Travis RC, Vermeulen R, Zheng T, Cogliano V, Straif K. Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med. 2011 Feb; 68(2):154-62.
    View in: PubMed
  34. Schernhammer ES, Thompson CA. Light at night and health: the perils of rotating shift work. Occup Environ Med. 2011 May; 68(5):310-1.
    View in: PubMed
  35. Kenborg L, Lassen CF, Ritz B, Schernhammer ES, Hansen J, Gatto NM, Olsen JH. Outdoor work and risk for Parkinson's disease: a population-based case-control study. Occup Environ Med. 2011 Apr; 68(4):273-8.
    View in: PubMed
  36. Rod NH, Hansen J, Schernhammer E, Ritz B. Major life events and risk of Parkinson's disease. Mov Disord. 2010 Aug 15; 25(11):1639-45.
    View in: PubMed
  37. Ritz B, Manthripragada AD, Qian L, Schernhammer E, Wermuth L, Olsen J, Friis S. Statin use and Parkinson's disease in Denmark. Mov Disord. 2010 Jul 15; 25(9):1210-6.
    View in: PubMed
  38. Bajaj A, Schernhammer ES, Haidinger G, Waldhör T. Trends in mortality from stroke in Austria, 1980-2008. Wien Klin Wochenschr. 2010 Jun; 122(11-12):346-53.
    View in: PubMed
  39. Schernhammer E, Haidinger G, Waldhör T, Vargas R, Vutuc C. A study of trends in beliefs and attitudes toward cancer. J Cancer Educ. 2010 Jun; 25(2):211-6.
    View in: PubMed
  40. Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, Schernhammer ES, Hunter DJ, Giovannucci EL, Fuchs CS, Ogino S. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer. 2010; 9:125.
    View in: PubMed
  41. Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S. L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol. 2010 May; 67(5):600-6.
    View in: PubMed
  42. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Grioni S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):729-37.
    View in: PubMed
  43. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens. 2010 Mar; 28(3):446-51.
    View in: PubMed
  44. Irahara N, Nosho K, Baba Y, Shima K, Lindeman NI, Hazra A, Schernhammer ES, Hunter DJ, Fuchs CS, Ogino S. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn. 2010 Mar; 12(2):177-83.
    View in: PubMed
  45. Bajaj A, Driver JA, Schernhammer ES. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010 May; 21(5):697-707.
    View in: PubMed
  46. Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut. 2010 Jun; 59(6):794-9.
    View in: PubMed
  47. Schernhammer ES, Haidinger G, Waldhör T, Vutuc C. Attitudes about the use of complementary and alternative medicine in cancer treatment. J Altern Complement Med. 2009 Oct; 15(10):1115-20.
    View in: PubMed
  48. Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH. Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology. 2009 Nov 3; 73(18):1462-8.
    View in: PubMed
  49. Schernhammer ES, Feskanich D, Niu C, Dopfel R, Holmes MD, Hankinson SE. Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts. Am J Clin Nutr. 2009 Oct; 90(4):975-85.
    View in: PubMed
  50. Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009 Nov; 20(9):1753-6.
    View in: PubMed
  51. Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Effect of light perception on menarche in blind women. Ophthalmic Epidemiol. 2009 Jul-Aug; 16(4):243-8.
    View in: PubMed
  52. Brown DL, Feskanich D, Sánchez BN, Rexrode KM, Schernhammer ES, Lisabeth LD. Rotating night shift work and the risk of ischemic stroke. Am J Epidemiol. 2009 Jun 1; 169(11):1370-7.
    View in: PubMed
  53. Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):74-9.
    View in: PubMed
  54. Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 2009 Aug 18; 281(1):1-7.
    View in: PubMed
  55. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst. 2008 Dec 3; 100(23):1734-8.
    View in: PubMed
  56. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One. 2008; 3(11):e3698.
    View in: PubMed
  57. Schernhammer ES, Giovannuccci E, Fuchs CS, Ogino S. A prospective study of dietary folate and vitamin B and colon cancer according to microsatellite instability and KRAS mutational status. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2895-8.
    View in: PubMed
  58. Feskanich D, Hankinson SE, Schernhammer ES. Nightshift work and fracture risk: the Nurses' Health Study. Osteoporos Int. 2009 Apr; 20(4):537-42.
    View in: PubMed
  59. Schernhammer ES, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology. 2008 Sep; 135(3):770-80.
    View in: PubMed
  60. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2008 Jun 18; 100(12):898-905.
    View in: PubMed
  61. Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res. 2008 Apr 1; 68(7):2507-13.
    View in: PubMed
  62. IARC, Monograph Working Group [Member]. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 98. Fire-fighting, painting, and nightshift work. Lyon: International Agency for Research on Cancer. 2008.
  63. Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Dynamics of the Prevalence of Atopic Disease in Austrian Children. Pediatr Allergy Immunol. 2008; 19(2):125-31.
  64. Moser M, Schernhammer E, Stevens R [editors]. “Rhythm and Cancer”. 2008.
  65. Schernhammer ES, Ogino S, Fuchs C. Folate and vitamin B6 intake and colon cancer in relation to p53 mutational status. Gastroenterology. 2008; 135(3):770-780.
  66. Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley, SW. Effect of light perception on menarche in blind women. Human Reproduction. 2008; (under review).
  67. Schernhammer ES, Waldhör T, Haidinger G, Vargas RB, Vutuc C. A study of trends in beliefs and attitudes toward cancer in Austria. J Cancer Edu. 2008; (under review).
  68. Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Time trends of the prevalence of asthma and allergic disease in Austrian children. Pediatr Allergy Immunol. 2008 Mar; 19(2):125-31.
    View in: PubMed
  69. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007 Nov 1; 67(21):10618-22.
    View in: PubMed
  70. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008 Jan; 134(1):21-8.
    View in: PubMed
  71. Megdal SP, Schernhammer ES. Correlates for poor sleepers in a Los Angeles high school. Sleep Med. 2007 Dec; 9(1):60-3.
    View in: PubMed
  72. Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer. 2007 Sep; 14(3):721-32.
    View in: PubMed
  73. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res. 2007 Aug 15; 67(16):7923-8.
    View in: PubMed
  74. Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ, Fuchs C. Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res. 2007 Jun 1; 67(11):5553-60.
    View in: PubMed
  75. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer. 2007 Jul 2; 97(1):98-104.
    View in: PubMed
  76. Dopfel RP, Schulmeister K, Schernhammer ES. Nutritional and lifestyle correlates of the cancer-protective hormone melatonin. Cancer Detect Prev. 2007; 31(2):140-8.
    View in: PubMed
  77. Schernhammer ES, Tworoger SS, Eliassen HA, Missmer SA, Holly J, Pollak MN, Hankinson SE. Body shape throughout life and correlations with insulin-like growth factors and growth hormone. Endocr Rel Cancer. 2007; 14(3):723-734.
  78. Straif K, Baan R, Grosse Y, Secretan B, Ghissassi FE, Bouvard V, Altieri A, Benbrahim-Ballaa L, Cogliano V, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8(12):1065-66.
  79. Schernhammer ES. Melatonin and Cancer [invited book chapter]. ‘Melatonin: From Molecules to Therapy’. S.R. Pandi-Perumal, Editor. 2007.
  80. Rea M, Biermann A, Figueiro M, Zhou Y, Schernhammer E. Light and Dark Activity and Rest in Dayshift and Nightshift Nurses. Pro Society for Light Treatment and Biological Rhythms (SLTBR) 19th Annual Meeting, Copenhagen, Denmark, 2007. Chronobiology International 2008. 2007.
  81. Kroenke CH, Spiegelman D, Manson J, Schernhammer ES, Colditz GA, Kawachi I. Work characteristics and incidence of type 2 diabetes in women. Am J Epidemiol. 2007 Jan 15; 165(2):175-83.
    View in: PubMed
  82. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer. 2006 Jun; 13(2):583-92.
    View in: PubMed
  83. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res. 2006 May 15; 66(10):5521-5.
    View in: PubMed
  84. Schernhammer E, Chen H, Ritz B. Circulating melatonin levels: possible link between Parkinson's disease and cancer risk? Cancer Causes Control. 2006 May; 17(4):577-82.
    View in: PubMed
  85. Moser M, Schaumberger K, Schernhammer E, Stevens RG. Cancer and rhythm. Cancer Causes Control. 2006 May; 17(4):483-7.
    View in: PubMed
  86. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer. 2006 Mar 27; 94(6):928-34.
    View in: PubMed
  87. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res. 2006 Mar; 40(2):116-24.
    View in: PubMed
  88. Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol. 2006 Mar 1; 24(7):1105-11.
    View in: PubMed
  89. Chen H, Schernhammer E, Schwarzschild MA, Ascherio A. A prospective study of night shift work, sleep duration, and risk of Parkinson's disease. Am J Epidemiol. 2006 Apr 15; 163(8):726-30.
    View in: PubMed
  90. Tworoger SS, Lee S, Schernhammer ES, Grodstein F. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord. 2006 Jan-Mar; 20(1):41-8.
    View in: PubMed
  91. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Willett WC, Fuchs CS. A Cyclin D A870G polymorphism and risk of colorectal adenomas as well as colorectal cancer in the Harvard cohorts. Br J Cancer. 2006; 94(6):928-34.
  92. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels K. Habitual duration of sleep and risk of breast cancer. Cancer Res. 2006; 66(10):5521-25.
  93. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006 Jan; 17(1):108-11.
    View in: PubMed
  94. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses' Health Study II. Endocr Rel Cancer. 2006; 13:583-92.
  95. Moser M, Schaumberger K, Schernhammer ES, Stevens RG. Cancer and Rhythm [Editorial]. Cancer Causes Control. 2006; 17(4):483-87.
  96. Schernhammer E, Enzinger P. Insulin-like growth factor receptor (IGFR-I) as a target for future therapeutic interventions [invited book chapter]. ‘Signaltransduktion in der Onkologie – Grundlagen und therapeutische Möglichkeiten’ [German]. UNI-MED Science Verlag. Hsgb. Dittrich C. 2006; 13:101-18.
  97. Schernhammer ES, Kroenke C, Dowsett M, Folkerd E, Hankinson SE. Life-style factors, steroid hormone levels, and correlations with urinary 6-sulphatoxy melatonin levels. J Pineal Res. 2006; 40(2):116-124.
  98. Kroenke CH, Bennett GG, Fuchs C, Giovannucci E, Kawachi I, Schernhammer E, Holmes MD, Kubzansky LD. Depressive symptoms and prospective incidence of colorectal cancer in women. Am J Epidemiol. 2005 Nov 1; 162(9):839-48.
    View in: PubMed
  99. Schernhammer ES, Hu FB, Giovannucci E, Michaud DS, Colditz GA, Stampfer MJ, Fuchs CS. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Biomarkers Prev. 2005 Sep; 14(9):2098-105.
    View in: PubMed
  100. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005 Sep; 41(13):2023-32.
    View in: PubMed
  101. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005 Aug 24; 294(8):914-23.
    View in: PubMed
  102. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005 Jul 20; 97(14):1084-7.
    View in: PubMed
  103. Vutuc C, Schernhammer ES, Haidinger G, Waldhör T. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Wien Klin Wochenschr. 2005 Jul; 117(13-14):457-61.
    View in: PubMed
  104. Schernhammer E. Taking their own lives -- the high rate of physician suicide. N Engl J Med. 2005 Jun 16; 352(24):2473-6.
    View in: PubMed
  105. Baur M, Schernhammer E, Gneist M, Sevelda P, Speiser P, Hudec M, Dittrich Ch. Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer. Br J Cancer. 2005 Mar 28; 92(6):1019-25.
    View in: PubMed
  106. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):699-704.
    View in: PubMed
  107. Stevens RG, Schernhammer E. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2005 Feb; 14(2):551; author reply 551.
    View in: PubMed
  108. Baur M, Schernhammer E, Gneist M, Sevelda P, Speiser P, Hudec M, Dittrich C. Phase I/II Study of oral etoposide plus GM-CSF as second line chemotherapy in platinum pretreated patients with advanced ovarian cancer. Br J Cancer 2005. 2005; 92(6):1019-1025.
  109. Kroenke C, Kawachi I, Kubzansky L, Schernhammer E. Three authors and Dr. Kubzansky reply [Letter to the Editor]. Am J Epidemiol. 2005; 162(11):1134-35.
  110. Schernhammer ES, Colditz GA. Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry. 2004 Dec; 161(12):2295-302.
    View in: PubMed
  111. Schernhammer ES, Hankinson SE, Rosner B, Kroenke CH, Willett WC, Colditz GA, Kawachi I. Job stress and breast cancer risk: the nurses' health study. Am J Epidemiol. 2004 Dec 1; 160(11):1079-86.
    View in: PubMed
  112. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004 Jul; 4(7):505-18.
    View in: PubMed
  113. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):936-43.
    View in: PubMed
  114. Kroenke CH, Hankinson SE, Schernhammer ES, Colditz GA, Kawachi I, Holmes MD. Caregiving stress, endogenous sex steroid hormone levels, and breast cancer incidence. Am J Epidemiol. 2004 Jun 1; 159(11):1019-27.
    View in: PubMed
  115. Fridrich P, Eappen S, Jaeger W, Schernhammer E, Zizza AM, Wang GK, Gerner P. Phase Ia and Ib study of amitriptyline for ulnar nerve block in humans: side effects and efficacy. Anesthesiology. 2004 Jun; 100(6):1511-8.
    View in: PubMed
  116. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. Sleep. 2004 May 1; 27(3):440-4.
    View in: PubMed
  117. Schernhammer E, Schulmeister K. Light at night and cancer risk. Photochem Photobiol. 2004 Apr; 79(4):316-8.
    View in: PubMed
  118. Schernhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer. 2004 Mar 8; 90(5):941-3.
    View in: PubMed
  119. Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med. 2004 Feb 3; 140(3):157-66.
    View in: PubMed
  120. Schernhammer ES, Kang JH, Chan AT, Michaud DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst. 2004 Jan 7; 96(1):22-8.
    View in: PubMed
  121. Schernhammer ES, Hankinson SE, Rosner B, Kroenke C, Speizer FE, Willett WC, Colditz GA, Kawachi I. Job stress and risk of breast cancer: The Nurses’ Health Study. Am J Epidemiol. 2004; 160(11):1079-1086.
  122. Schernhammer ES, Schulmeister K. Light at night and cancer risk [invited review]. Photochem Photobiol. 2004; 79(4):316-18.
  123. Schernhammer ES, Schulmeister K. Epidemiology of light at night and cancer risk. 2004.
  124. Baur M, Schernhammer E, Sevelda P, Speiser P, Gneist M, Hudec M, Dittrich C. Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum pretreated patients with advanced ovarian cancer. Onkologie (Pro ‘Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellsachaften für Hämatologie und Onkologie, Innsbruck, Austria). 2004; 27(Suppl 3):643.
  125. Schernhammer ES, Hunter DJ, Pollak M, Hankinson SE. A growth hormone polymorphism at position 1663 in intron 4 of the GH1 gene is not associated with breast cancer risk. Int J Cancer Prev. 2004; 1(1):33-37.
  126. Schernhammer ES. Harvard launches a workshop series targeting the control of obesity in the US. Cancer Causes Control. 2003 Dec; 14(10):1009-12.
    View in: PubMed
  127. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN. Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer. 2003 Oct 20; 107(1):60-4.
    View in: PubMed
  128. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003 Jun 4; 95(11):825-8.
    View in: PubMed
  129. Schernhammer ES, Leitzmann MF, Michaud DS, Speizer FE, Giovannucci E, Colditz GA, Fuchs CS. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer. 2003 Jan 13; 88(1):79-83.
    View in: PubMed
  130. Schernhammer ES, Hankinson SE. Light at night: A novel risk factor for cancer in shift workers? [invited review]. Clinics in Occupational and Environmental Medicine/ Chronobiology and Shiftwork. 2003; 3(2):263-78.
  131. Schernhammer ES, Dittrich CH. Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors [invited review]. Wien Med Wochenschrift. 2003; 153(5-6):1-12.
  132. Schernhammer ES. Harvard launches a workshop series targeting the control of obesity in the U.S. Cancer Causes & Control. 2003; 14(10):1009-12.
  133. Schernhammer ES, Dittrich C. [Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors]. Wien Med Wochenschr. 2003; 153(5-6):104-15.
    View in: PubMed
  134. Hankinson SE, Schernhammer ES. Insulin-like growth factor and breast cancer risk: evidence from observational studies [invited review]. Breast Diseases. 2003; 17:27-40.
  135. Schernhammer ES, Hankinson SE. Epidemiologic approaches to evaluating IGF and cancer risk [invited book chapter]. Insulin-like Growth Factors. Landes Bioscience; LeRoith D, Zumkeller W, Baxter R, editors. 2003; Chapter 19:317-38 .
  136. Hankinson SE, Schernhammer ES. Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Dis. 2003; 17:27-40.
    View in: PubMed
  137. Schernhammer ES. In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor? Cancer Causes Control. 2002 Aug; 13(6):505-8.
    View in: PubMed
  138. Schernhammer ES, Michaud DS, Leitzmann MF, Giovannucci E, Colditz GA, Fuchs CS. Gallstones, cholecystectomy, and the risk for developing pancreatic cancer. Br J Cancer. 2002 Apr 8; 86(7):1081-4.
    View in: PubMed
  139. Schernhammer ES, Schulmeister K. Night Work and Cancer Risk. 2002.
  140. Schernhammer ES, Colditz GA. Response: Night shift work, light at night, and risk of breast cancer [editorial]. J Natl Cancer Inst. 2002; 94(7):530-1.
  141. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001 Oct 17; 93(20):1563-8.
    View in: PubMed
  142. Kienzer H, Baur M, Faezeny M, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Point J, Dittrich C. Intra-individual dose escalation with carboplatin/mitomycin C in advanced breast cancer. Ann Oncol (Pro ESMO, Athens, Greece). 1998; 9(Suppl 4):125.
  143. Kienzer H, Schweiger J, Baur M, DeSantis M, Poehnl R, Gerber E, Soucek B, Schernhammer E, Postner G, Pont J, Schlappack A, Schratter-Sehn A, Wicke W, Dittrich CH. Docetaxel/cisplatin as first-line therapy in head and neck cancer. Pro ASCO. 1998; 17(1566).
  144. Baur M, Kienzer H, Schweiger J, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Pont J, Schratter-Sehn A, Wicke W, Dittrich CH. First-line therapy in head and neck cancer with docetaxel/cisplatin. Ann Oncol (Pro ESMO, Athens, Greece). 1998; 9(Suppl 4):362.
  145. Fazeny B, Stubenvoll R, DeSantis M, Poehnl R, Soucek B, Schernhammer E, Postner G, Kienzer H, Kraus R, Pont J, Dittrich CH. Carboplatin/mitomycin C (MMC) as salvage therapy with intraindividual dose escalation in advanced breast cancer. Pro ASCO, Los Angeles, CA. 1998; 17(489).
  146. Czejka M, Bandak S, Simon D, Schüller J, Weiss C, Schernhammer E. Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine. Z Naturforsch C. 1995 Jul-Aug; 50(7-8):565-70.
    View in: PubMed
  147. Czejka M, Schüller J, Schernhammer E, Bandak S. [Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion]. Pharmazie. 1995 Jun; 50(6):416-9.
    View in: PubMed
  148. Bandak S, Czejka M, Schüller J, Schernhammer E. Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells. Arzneimittelforschung. 1995 Feb; 45(2):212-5.
    View in: PubMed
  149. Thürlimann B, Kröger N, Greiner J, Mross K, Schüller J, Schernhammer E, Schumacher K, Gastl G, Hartlapp J, Kupper H, et al. Dexverapamil to overcome epirubicin resistance in advanced breast cancer. J Cancer Res Clin Oncol. 1995; 121 Suppl 3:R3-6.
    View in: PubMed
  150. Czejka M, Bandak S, Simon D, Schueller J, Weiss C, Schernhammer E. Pharmacokinetic interaction between 4’-epidoxorubicin and the multidrug resistance reverting agent quinine. Z Naturforschung. 1995; 50(7-8):565-70.
  151. Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G. Serum and tissue levels of d- and 1- Methyltetrahydrofolic acid (MTHF) after i.v. bolus of (d,1) MTHF. Fruehjahrstagung der Oesterreichischen Gesellschaft fuer Haematologie und Onkologie, Wien. 1994.
  152. Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G. Serum and tissue levels of d- and 1- Methyltetrahydrofolic acid (MTHF) after i.v. bolus of (d,1). MTHF, Pro AACR, San Francisco, CA. 1994; 35(2561).
  153. Schueller J, Czejka M, Bandak S, Wirth M, Schernhammer E, Schernthaner G. Epirubicin pharmacokinetics, influence of interferon alfa 2b in advanced cancer patients. Pro ASCO, Dallas, TX. 1994; 13(446).
  154. Schueller J, Czejka M, Bandak S, Schernhammer E, Schernthaner G. Pharmacokinetics of racemic or L-Leucovorin in serum and red blood cells. Annual Congress of the German and the Austrian Society of Hematology and Oncology, Essen. Ann Hematol. 1993; 2993:67 (Suppl).
  155. Schueller J, Schernhammer E, Weiss C, Fogl U. Therapie von Karzinomschmerzen. 3. Wiener Dialog ueber Ganzheitsmedizin und Schmerz. 1993.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu. SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).
Schernhammer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_